IP Verse

Insulin Formulations For Rapid Uptake - EP3372238

The patent EP3372238 was granted to ELI Lilly on Nov 18, 2020. The application was originally filed on Mar 3, 2010 under application number EP18155633A. The patent is currently recorded with a legal status of "Revoked".

EP3372238

ELI LILLY
Application Number
EP18155633A
Filing Date
Mar 3, 2010
Status
Revoked
Jul 18, 2025
Grant Date
Nov 18, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOHMANNAug 17, 2021BOHMANNADMISSIBLE
SCORPIOAug 16, 2021SAGITTARIUSADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONEP1740154
OPPOSITIONUS2007206081
OPPOSITIONUS2008090753
OPPOSITIONUS2008194461
OPPOSITIONUS4476118
OPPOSITIONUS5045454
OPPOSITIONWO2005089722
OPPOSITIONWO2007041481
OPPOSITIONWO2007121256
OPPOSITIONWO2008013955
OPPOSITIONWO2008152106
OPPOSITIONWO2009048959
OPPOSITIONWO2009134380
OPPOSITIONWO2010102020
OPPOSITIONWO2010149772
OPPOSITIONWO9816205
OTHERUS4476118
OTHERWO2008152106
SEARCHWO2005089722
SEARCHWO2007041481
SEARCHWO2007121256
SEARCHWO2008084237
SEARCHWO2009134380

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- A. PLUM; H. AGERSO; L. ANDERSEN, "Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs", Drug Metab. Dispos., (20000000), vol. 28, no. 2, pages 155 - 60-
OPPOSITION- Anonymous, "Insulin", NICE, page 1, URL: https://bnf.nice.org.uk/treatmentsummary/insulin-2.html-
OPPOSITION- BRANGE J, "Stability of Insulin - Studies on the physical and chemical stability of insulin in pharmaceutical formulation", Kluwer Acadamic Publishers Group, (19940000), pages 1 - 31, XP055560782-
OPPOSITION- MARUNAKA Y., "Roles of interstitial fluid pH in diabetes mellitus: Glycolysis and mitochondrial function", World J. Diabetes, (20150215), vol. 6, no. 1, pages 125 - 135, XP055839117-
OPPOSITION- PRABHU et al., "A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species", Int. J. Pharmaceutics, (20010000), vol. 217, pages 71 - 78, XP055560779-
OPPOSITION- PRABHU S. et al., "A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ironic species", Int. J. Pharm., (20010000), vol. 217, pages 71 - 78, XP055560779-
OPPOSITION- STEINER S. et al., "A novel insulin formulation with a more rapid onset of action", Diabetologia, (20080000), vol. 51, pages 1602 - 1606, XP019618517-
OPPOSITION- Technical primer of ionisation forms of citrate/citric acid-
OTHER- PRABHU et al., "A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species", Int. J. Pharmaceutics, (20010000), vol. 217, pages 71 - 78, XP055560779-
SEARCH- STEINER S. ET AL., "A novel insulin formulation with a more rapid onset of action", DIABETOLOGIA ; CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM, SPRINGER, BERLIN, DE, (20080719), vol. 51, no. 9, ISSN 1432-0428, pages 1602 - 1606, XP019618517 [X] 4,15 * the whole document *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents